February's Most Popular Stories
By Arvind Sommi
-min(1)(2)(1)(2).png)
In case you missed them, below you'll find our top five stories from February 2023. This month's best stories cover various topics including type 2 therapies, the latest on glucose monitoring technology, conference coverage, and more!
1. Semaglutide, Tirzepatide, CagriSema, Oh My! Emerging Treatment Options for Obesity and Type 2 Diabetes
At ATTD 2023, a panel of experts discussed the latest medications for weight loss and the treatment of obesity. The panel highlighted two FDA-approved drugs, as well as a promising combination therapy in development.
2. The Current State of Non-Invasive Glucose Monitoring
Researchers at ATTD 2023 discussed some of the latest advancements in non-invasive glucose monitoring, including two new approaches to tackling this challenge.
3. Sex and Diabetes
It’s not always easy to talk about sex, regardless of whether you have diabetes or not. If you are a person living with diabetes, here are some important things to bear in mind when you're in the bedroom.
4. How People With Diabetes Are Getting By During the Ozempic Shortage
The world’s hottest new miracle drug for type 2 diabetes, Ozempic (semaglutide), has surged in popularity among people with and without diabetes looking to lose weight, including celebrities and influencers, causing a global shortage. So, what are people with diabetes supposed to do?
5. Dexcom G7 Now Available in US
The long-awaited US launch of Dexcom G7 is here! G7 improves on Dexcom’s current continuous glucose monitoring (CGM) system, the G6, with greater accuracy, smaller size, easier insertion, and more.
